Audubon, PA-based Globus Medical, Inc. has an extensive portfolio comprising ... Globus Medical registered the highest number of Excelsius unit placements since launch. Zacks Investment Research ...
NuVasive, Inc. NuVasive is a company specializing ... 2023 that it is going to merge with Globus Medical (GMED). Globus also has its own VR solution, with the Exclesius GPS Navigation Robot and the ...
Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...
NYSE:GMED opened at $92.35 on Thursday. The company has a market cap of $12.58 billion, a PE ratio of 137.83, a price-to-earnings-growth ratio of 1.78 and a beta of 1.19. The company has a 50 day ...
The nation’s GPs want the federal government to invest ... with a total funding requirement of more than $3 billion. The medical system is under stress. Getty It will argue the measures will ...
Globus Medical and Nevro Preliminary Full-Year 2024 Revenue Outlook: On January 8, 2025, Globus Medical announced preliminary 2024 net sales of $2.52 billion, an increase of 60.6% over prior year ...
Globus Medical (GMED) and Nevro Corp. (NVRO) have entered into a definitive agreement for Globus Medical to acquire all shares of Nevro in an ...
GPS Wealth Strategies Group LLC’s holdings in Meta Platforms were worth $3,720,000 at the end of the most recent reporting period. Other hedge funds also recently added to or reduced their ...
In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target ...
Globus Medical (NYSE:GMED) said it has agreed to buy Nevro (NVRO) through an all-cash deal with an equity value of around $250M. Under the deal, Globus Medical (NYSE:GMED) will buy all of Nevro's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results